Inhibition of Kv1.1 by KAaH2 toxin targeting specifically Kv1.1 was shown to inhibit proliferation of glioblastoma via the Epidermal Growth Factor Receptor (EGFR) signaling pathway (Aissaoui et al., 2018). Here, KCNA1 is linked to glioblastoma.